Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Medicine (Baltimore) ; 97(49): e13424, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30544421

RESUMO

PURPOSE: Many studies have demonstrated the advantage of maintaining intraoperative deep neuromuscular block (NMB) with sugammadex. This trial is designed to evaluate the impact of muscle relaxation during laparoscopic subtotal gastrectomy on the oncological benefits, particularly in obese patients with gastric cancer. MATERIALS AND METHODS: This is a double-blind, randomized controlled multicenter prospective trial. Patients with clinical stage I-II gastric cancer with a body mass index of 25 and over, who undergo laparoscopic subtotal gastrectomy will be eligible for trial inclusion. The patients will be randomized into a deep NMB group or a moderate NMB group with a 1:1 ratio. A total of 196 patients (98 per group) are required. The primary endpoint is the number of harvested lymph nodes, which is a critical index of the quality of surgery in gastric cancer treatment. The secondary endpoints are surgeon's surgical condition score, patient's sedation score, and surgical outcomes including peak inspiratory pressure, operation time, postoperative pain, and morbidity. DISCUSSION: This is the first study that compares deep NMB with moderate NMB during laparoscopic gastrectomy in obese patients with gastric cancer. We hope to show the oncologic benefits of deep NMB compared with moderate NMB during subtotal gastrectomy. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov (NCT03196791), date of registration: October 10, 2017.


Assuntos
Gastrectomia , Laparoscopia , Bloqueio Neuromuscular/métodos , Obesidade/complicações , Neoplasias Gástricas/complicações , Neoplasias Gástricas/terapia , Adulto , Idoso , Método Duplo-Cego , Humanos , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Seleção de Pacientes , Neoplasias Gástricas/patologia , Resultado do Tratamento , Adulto Jovem
2.
Sci Rep ; 6: 32322, 2016 08 31.
Artigo em Inglês | MEDLINE | ID: mdl-27577999

RESUMO

Triclosan (TCS) is a widely used antimicrobial agent and TCS resistance is considered to have evolved in diverse organisms with extensive use of TCS, but distribution of TCS resistance has not been well characterized. Functional screening of the soil metagenome in this study has revealed that a variety of target enoyl acyl carrier protein reductases (ENR) homologues are responsible for the majority of TCS resistance. Diverse ENRs similar to 7-α-hydroxysteroid dehydrogenase (7-α-HSDH), FabG, or the unusual YX7K-type ENR conferred extreme tolerance to TCS. The TCS-refractory 7-α HSDH-like ENR and the TCS-resistant YX7K-type ENR seem to be prevalent in human pathogenic bacteria, suggesting that a selective enrichment occurred in pathogenic bacteria in soil. Additionally, resistance to multiple antibiotics was found to be mediated by antibiotic resistance genes that co-localize with TCS resistance determinants. Further comparative analysis of ENRs from 13 different environments has revealed a huge diversity of both prototypic and metagenomic TCS-resistant ENRs, in addition to a selective enrichment of TCS-resistant specific ENRs in presumably TCS-contaminated environments with reduced ENR diversity. Our results suggest that long-term extensive use of TCS can lead to the selective emergence of TCS-resistant bacterial pathogens, possibly with additional resistance to multiple antibiotics, in natural environments.


Assuntos
Bactérias/efeitos dos fármacos , Resistência Microbiana a Medicamentos/genética , Enoil-(Proteína de Transporte de Acila) Redutase (NADH)/genética , Metagenoma/genética , Oxirredutases do Álcool/genética , Bactérias/genética , Bactérias/patogenicidade , Resistência Microbiana a Medicamentos/efeitos dos fármacos , Enoil-(Proteína de Transporte de Acila) Redutase (NADH)/efeitos dos fármacos , Humanos , Hidroxiesteroide Desidrogenases/genética , Metagenoma/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Triclosan/uso terapêutico
3.
J Microbiol Biotechnol ; 25(4): 511-20, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25370725

RESUMO

Triclosan, the widely used biocide, specifically targets enoyl-acyl carrier protein reductase (ENR) in the bacterial fatty acid synthesis system. Although the fish pathogen Aeromonas salmonicida subsp. salmonicida exhibits triclosan resistance, the nature of this resistance has not been elucidated. Here, we aimed to characterize the triclosan resistance of A. salmonicida subsp. salmonicida causing furunculosis. The fosmid library of triclosan-resistant A. salmonicida subsp. salmonicida was constructed to select a fosmid clone showing triclosan resistance. With the fosmid clone showing triclosan resistance, a subsequent secondary library search resulted in the selection of subclone pTSR-1. DNA sequence analysis of pTSR-1 revealed the presence of a chromosomal-borne fabV-encoding ENR homolog. The ENR of A. salmonicida (FabVas) exhibited significant homology with previously known FabV, including the catalytic domain YX(8)K. fabVas introduction into E. coli dramatically increased its resistance to triclosan. Heterologous expression of FabVas might functionally replace the triclosan-sensitive FabI in vivo to confer E. coli with triclosan resistance. A genome-wide search for fabVas homologs revealed the presence of an additional fabV gene (fabVas2) paralog in A. salmonicida strains and the fabVas orthologs from other gram-negative fish pathogens. Both of the potential FabV ENRs expressed similarly with or without triclosan supplement. This is the first report about the presence of two potential FabV ENRs in a single pathogenic bacterium. Our result suggests that triclosan-resistant ENRs are widely distributed in various bacteria in nature, and the wide use of this biocide can spread these triclosan-tolerant ENRs among fish pathogens and other pathogenic bacteria.


Assuntos
Aeromonas salmonicida/efeitos dos fármacos , Aeromonas salmonicida/enzimologia , Anti-Infecciosos Locais/farmacologia , Farmacorresistência Bacteriana , Enoil-(Proteína de Transporte de Acila) Redutase (NADPH, B-Específica)/metabolismo , Triclosan/farmacologia , Aeromonas salmonicida/genética , Sequência de Aminoácidos , Animais , Clonagem Molecular , Farmacorresistência Bacteriana/genética , Enoil-(Proteína de Transporte de Acila) Redutase (NADPH, B-Específica)/química , Enoil-(Proteína de Transporte de Acila) Redutase (NADPH, B-Específica)/genética , Peixes/microbiologia , Regulação Bacteriana da Expressão Gênica , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular , Plasmídeos/genética , Domínios e Motivos de Interação entre Proteínas , Alinhamento de Sequência , Transcrição Gênica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA